ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

PCRX Pacira BioSciences Inc

27,17
-0,15 (-0,55%)
Dernière mise à jour : 21:45:30
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Pacira BioSciences Inc PCRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,15 -0,55% 27,17 21:45:30
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
27,68 27,05 27,77 27,32
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
30/4/202414:00GLOBEPacira to Report First Quarter 2024 Financial Results on..
02/4/202414:00GLOBEPacira BioSciences to Participate in Fireside Chat at the..
13/3/202412:00GLOBEPacira BioSciences Announces PCRX-201 Granted Regenerative..
06/3/202414:00GLOBEPacira BioSciences to Participate in Fireside Chat at the..
29/2/202421:33EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202414:03EDGAR2Form 8-K - Current report
29/2/202414:00GLOBEPacira BioSciences Reports Fourth Quarter and Full-Year 2023..
22/2/202414:00GLOBEPacira to Report 2023 Financial Results on Thursday February..
15/2/202414:36GLOBEPacira Announces Publication of Pivotal Study of EXPAREL as..
07/2/202422:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202414:00GLOBEPacira BioSciences Awarded Brand Pharmaceuticals Agreement..
01/2/202416:45PRNUSG.O.A.T. Bowl I Registration Open to 4 Additional Pickleball..
04/1/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202423:02EDGAR2Form 8-K - Current report
04/1/202423:00GLOBEPacira Reports Preliminary Unaudited Fourth Quarter and..
03/1/202414:00GLOBEPacira BioSciences to Present at the 42nd Annual J.P. Morgan..
21/12/202313:33EDGAR2Form 8-K - Current report
21/12/202313:30GLOBEPacira Appoints Frank D. Lee as Chief Executive Officer
08/12/202301:44EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/11/202315:41EDGAR2Form 144 - Report of proposed sale of securities
10/11/202313:30GLOBEPacira Announces FDA Approval of Expanded EXPAREL Label to..
07/11/202314:00GLOBEPacira BioSciences to Participate in Fireside Chat at Two..
02/11/202319:59EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202313:01EDGAR2Form 8-K - Current report
02/11/202313:00GLOBEPacira BioSciences Reports Third Quarter 2023 Financial..
26/10/202314:00GLOBEPacira to Report Third Quarter 2023 Financial Results on..
12/10/202314:00GLOBEAmerican Society of Anesthesiologists Announces New Industry..
11/10/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202322:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/10/202322:43EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/10/202322:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/10/202322:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/10/202314:02EDGAR2Form 8-K - Current report
10/10/202314:00GLOBEPacira BioSciences Appoints Four New Independent Directors..
02/10/202314:00GLOBEAmerican Society of Anesthesiologists and Pacira..
26/9/202322:32EDGAR2Form 8-K - Current report
26/9/202322:30GLOBEPacira BioSciences Announces Leadership Succession Plan
11/9/202322:27EDGAR2Form 8-K - Current report
06/9/202314:00GLOBEPacira BioSciences Announces Fireside Chat at the H.C...
04/8/202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/8/202321:54EDGAR2Form 144 - Report of proposed sale of securities
02/8/202320:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202314:02EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

Delayed Upgrade Clock